Nephros (NEPH) Shares Outstanding (2010 - 2026)

Nephros has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $10.9 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 2.45% year-over-year to $10.9 million in Q2 2026; TTM through Jun 2026 was $10.9 million, a 2.45% increase from a year earlier, with the FY2025 full-year figure at $10.6 million, up 0.94% from the prior year.
• Shares Outstanding (Entity) was $10.9 million for Q2 2026 at Nephros, roughly flat from $10.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $10.9 million in Q2 2026, with the low at $10.3 million in Q4 2022.
• Average Shares Outstanding (Entity) over 5 years is $10.5 million, with a median of $10.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) advanced 3.68% in 2022, then rose 0.01% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $10.3 million in 2022, then increased by 2.39% to $10.5 million in 2023, then advanced by 0.01% to $10.5 million in 2024, then climbed by 0.94% to $10.6 million in 2025, then gained by 2.03% to $10.9 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $10.9 million (Q2 2026), $10.8 million (Q1 2026), and $10.6 million (Q4 2025), per Business Quant data.